Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2000
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040444 Process for preparing furan nitrone compounds
03/21/2000US6040442 Process for preparing 1,2,5-thiadiazole containing ethers
03/21/2000US6040336 Treating bacterially induced meningitis
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040314 Bicyclic isothiourea derivatives useful in therapy
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040302 1,4-disubstituted piperazines
03/21/2000US6040292 Methods for treating diabetes
03/21/2000US6040289 Active drug treating obesity
03/21/2000US6040168 Dna and amino acid sequence of protein involved in neurotransmission and neurodevelopment; for diagnosis and treatment of schizophrenia and other nervous system disorders; screening drugs
03/21/2000US6039947 Peptides and amino acid sequences for stimulating for treatment of multiple sclerosis
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014115A1 Mc4-r as target for the identification of compounds used to treat drug addiction
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014067A1 Piperidine derivatives
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000WO2000014064A2 Gaba uptake inhibitors having a pyrrolidine structure
03/16/2000WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000WO2000013705A1 Use of tgf-beta inhibitors for treating cerebral disorders
03/16/2000WO2000013696A1 Composition for improving mental capabilities in mammals
03/16/2000WO2000013682A2 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
03/16/2000WO2000013672A1 New solid dose form of nanoparticulate naproxen
03/16/2000WO2000013650A2 Neuroprotection
03/16/2000WO2000013648A2 Method for the preparation of citalopram
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
03/16/2000WO1999030548B1 Method for the preparation of citalopram
03/16/2000DE19841941A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins
03/16/2000CA2343531A1 Gaba uptake inhibitors having a pyrrolidine structure
03/16/2000CA2343214A1 Neuroprotection
03/16/2000CA2343168A1 Piperidine derivatives
03/16/2000CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342855A1 Novel pyranoses
03/16/2000CA2342208A1 Use of tgf-beta inhibitors for treating cerebral disorders
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2340323A1 Mc4-r as target for the identification of compounds used to treat drug addiction
03/16/2000CA2306165A1 Composition for improving mental capabilities in mammals
03/15/2000EP0985666A1 Substituted indole compounds as COX-2 inhibitors
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0984987A2 A soluble laminin receptor precursor and methods to ihnibit its interactions
03/15/2000EP0984970A1 Spiro-quinuclidine derivatives, their preparation and use
03/15/2000EP0984968A1 Salts of aromatic sulphonic acids
03/15/2000EP0984966A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984956A1 Indoline derivatives as 5ht2c receptor antagonists
03/15/2000EP0984952A1 A new salt
03/15/2000EP0984943A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
03/15/2000EP0984787A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
03/15/2000EP0984786A1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
03/15/2000EP0984781A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
03/15/2000EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists
03/15/2000EP0618797B1 Pharmaceutical preparations containing bilobalid for the treatment of nervous tension and anxiety
03/15/2000CN1247537A Sulfonamide compounds having 5-HT receptor activity
03/15/2000CN1247534A Benzofurazan compounds which enhance AMPA receptor activity
03/15/2000CN1247471A Oxacarbazepine filme-coated tablets
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1247065A Medicine for treating trigeminal neuralgia
03/15/2000CN1050365C Method for prepn. of hexan-2-olefin pyranoseoside of alcohol and phenol
03/15/2000CN1050358C New tetracyclic piperidine and 1,4-oxazine compounds, its prepn. and pharmaceutical compsns. containing them
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037373 Treating nervous system, cytological, hormonal, gastrointestinal and liver disorders
03/14/2000US6037370 Methods and compositions for stimulating neurite growth
03/14/2000US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors
03/14/2000US6037347 Comprising a compound which has an acetylcholinesterase-inhibitory action or exhibits muscarinergic action and a compound which increases the endogenous extracellular adenosine level
03/14/2000US6037342 Serotonin 5-HT3 receptor partial activator
03/14/2000US6037327 Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6036975 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/14/2000US6036957 Immunology suppression with cd4 and t-cells reactive with mylin protein
03/14/2000US6036954 Polypeptides with sequence
03/14/2000CA2117643C Indole derivatives
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000013015A1 Modulating multiple lineage kinase proteins
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
1 ... 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 ... 1833